HomeComparePEPS vs MRK

PEPS vs MRK: Dividend Comparison 2026

PEPS yields 1.02% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $35.6K in total portfolio value
10 years
PEPS
PEPS
● Live price
1.02%
Share price
$27.99
Annual div
$0.29
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.1K
Annual income
$109.40
Full PEPS calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PEPS vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPEPSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PEPS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PEPS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PEPS
Annual income on $10K today (after 15% tax)
$87.01/yr
After 10yr DRIP, annual income (after tax)
$92.99/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,235.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PEPS + MRK for your $10,000?

PEPS: 50%MRK: 50%
100% MRK50/50100% PEPS
Portfolio after 10yr
$39.0K
Annual income
$4,953.77/yr
Blended yield
12.72%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PEPS
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PEPS buys
0
MRK buys
0
No recent congressional trades found for PEPS or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPEPSMRK
Forward yield1.02%2.76%
Annual dividend / share$0.29$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$21.1K$56.8K
Annual income after 10y$109.40$9,798.13
Total dividends collected$1.1K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PEPS vs MRK ($10,000, DRIP)

YearPEPS PortfolioPEPS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,802$102.36$11,206$366.19$404.00MRK
2$11,662$103.34$12,650$502.35$988.00MRK
3$12,582$104.27$14,407$694.19$1.8KMRK
4$13,568$105.14$16,585$967.82$3.0KMRK
5$14,624$105.96$19,342$1,363.89$4.7KMRK
6$15,755$106.73$22,913$1,947.19$7.2KMRK
7$16,965$107.46$27,662$2,823.89$10.7KMRK
8$18,261$108.15$34,159$4,173.35$15.9KMRK
9$19,648$108.79$43,337$6,308.80$23.7KMRK
10$21,132$109.40$56,776$9,798.13$35.6KMRK

PEPS vs MRK: Complete Analysis 2026

PEPSStock

PEPS is an actively managed fund that seeks long-term capital appreciation through a US large-cap equity portfolio while employing a beta-neutral call overwriting strategy. The fund specifically invests in stocks of the Solactive GBS United States 500 Index. The funds options strategy combines selling short-dated, out-of-the-money S&P 500 Index call options with offsetting long equity exposure, including investments in futures and FLEX Options that reference the S&P 500 Index and SPY ETF. The fund's performance is dependent on the equity portfolio. To avoid being subject to the straddle rules, the fund limits overlap between its equity investments and the options' underlying constituents. It also utilizes tax loss harvesting within the equity portfolio. As a result of writing call options, the fund may forgo upside participation. However, the funds sub-adviser will seek to ladder the written call option positions to mitigate this risk.

Full PEPS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PEPS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PEPS vs SCHDPEPS vs JEPIPEPS vs OPEPS vs KOPEPS vs MAINPEPS vs JNJPEPS vs ABBVPEPS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.